0001144204-19-030986 Sample Contracts

Marker Therapeutics, Inc., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 20__ Debt Securities

Indenture • June 14th, 2019 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Indenture
• Filed
  June 14th, 2019
• Company
  Marker Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Indenture, dated as of [·], 20__, among Marker Therapeutics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):

Marker Therapeutics, Inc. and _____________, As Warrant Agent Form of Preferred Stock Warrant Agreement Dated As Of __________

Preferred Stock Warrant Agreement • June 14th, 2019 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Preferred Stock Warrant Agreement
• Filed
  June 14th, 2019
• Company
  Marker Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Preferred Stock Warrant Agreement (this “Agreement”), dated as of [●], between Marker Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Marker Therapeutics, Inc. and _____________, As Warrant Agent Form of Common Stock Warrant Agreement Dated As Of __________

Common Stock Warrant Agreement • June 14th, 2019 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Common Stock Warrant Agreement
• Filed
  June 14th, 2019
• Company
  Marker Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between Marker Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Marker Therapeutics, Inc. and _____________, As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of __________

Debt Securities Warrant Agreement • June 14th, 2019 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Debt Securities Warrant Agreement
• Filed
  June 14th, 2019
• Company
  Marker Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Marker Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).